

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 9.99001521 |
| 2 | ether lipid metabolic process (GO:0046485) | 9.86278469 |
| 3 | positive regulation of chemokine biosynthetic process (GO:0045080) | 9.86211416 |
| 4 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 9.32039681 |
| 5 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 8.95015792 |
| 6 | microglial cell activation (GO:0001774) | 8.83872410 |
| 7 | regulation of MHC class II biosynthetic process (GO:0045346) | 8.70345985 |
| 8 | pyrimidine nucleotide catabolic process (GO:0006244) | 8.13473757 |
| 9 | myeloid leukocyte mediated immunity (GO:0002444) | 7.36241826 |
| 10 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 6.94196774 |
| 11 | regulation of growth of symbiont in host (GO:0044126) | 6.94196774 |
| 12 | negative regulation of growth of symbiont in host (GO:0044130) | 6.94196774 |
| 13 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 6.94196774 |
| 14 | induction of positive chemotaxis (GO:0050930) | 6.38132121 |
| 15 | alanine transport (GO:0032328) | 6.26365392 |
| 16 | striated muscle atrophy (GO:0014891) | 6.25331227 |
| 17 | macrophage chemotaxis (GO:0048246) | 6.17106602 |
| 18 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 6.06860219 |
| 19 | L-serine transport (GO:0015825) | 6.01784416 |
| 20 | negative regulation of interleukin-8 production (GO:0032717) | 5.91315553 |
| 21 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 5.87050865 |
| 22 | glial cell migration (GO:0008347) | 5.85101908 |
| 23 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 5.67568756 |
| 24 | skeletal muscle adaptation (GO:0043501) | 5.61549647 |
| 25 | glycerol ether metabolic process (GO:0006662) | 5.56543784 |
| 26 | muscle atrophy (GO:0014889) | 5.41281117 |
| 27 | serine transport (GO:0032329) | 5.21703804 |
| 28 | ether metabolic process (GO:0018904) | 5.14372809 |
| 29 | negative regulation of chemokine production (GO:0032682) | 4.86053310 |
| 30 | deoxyribonucleotide catabolic process (GO:0009264) | 4.82677786 |
| 31 | killing of cells of other organism (GO:0031640) | 4.71360664 |
| 32 | disruption of cells of other organism (GO:0044364) | 4.71360664 |
| 33 | histone deubiquitination (GO:0016578) | 4.70004777 |
| 34 | deoxyribose phosphate catabolic process (GO:0046386) | 4.56986927 |
| 35 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.48765583 |
| 36 | macrophage activation (GO:0042116) | 4.30728303 |
| 37 | C4-dicarboxylate transport (GO:0015740) | 4.28088044 |
| 38 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 4.22454468 |
| 39 | membrane protein intracellular domain proteolysis (GO:0031293) | 4.10267423 |
| 40 | protein localization to microtubule (GO:0035372) | 3.99359048 |
| 41 | leukocyte mediated cytotoxicity (GO:0001909) | 3.93853346 |
| 42 | cellular response to exogenous dsRNA (GO:0071360) | 3.74619071 |
| 43 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.68030541 |
| 44 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.67926596 |
| 45 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.61603851 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 3.56197959 |
| 47 | protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 3.54570222 |
| 48 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.51347733 |
| 49 | oxidative demethylation (GO:0070989) | 3.47925586 |
| 50 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.44244153 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 3.43985552 |
| 52 | basic amino acid transport (GO:0015802) | 3.40008033 |
| 53 | interaction with symbiont (GO:0051702) | 3.38950510 |
| 54 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.37197578 |
| 55 | ventricular system development (GO:0021591) | 3.33826395 |
| 56 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.31527595 |
| 57 | positive regulation of positive chemotaxis (GO:0050927) | 3.29742631 |
| 58 | inflammatory response to antigenic stimulus (GO:0002437) | 3.28047685 |
| 59 | mitotic chromosome condensation (GO:0007076) | 3.24394577 |
| 60 | response to fungus (GO:0009620) | 3.23038361 |
| 61 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.21410758 |
| 62 | regulation of vascular permeability (GO:0043114) | 3.20763726 |
| 63 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.20583912 |
| 64 | genetic imprinting (GO:0071514) | 3.14218689 |
| 65 | defense response to Gram-negative bacterium (GO:0050829) | 3.13143410 |
| 66 | regulation of positive chemotaxis (GO:0050926) | 3.13070924 |
| 67 | positive regulation of interleukin-1 production (GO:0032732) | 3.10494376 |
| 68 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.04241406 |
| 69 | regulation of chemokine production (GO:0032642) | 3.01468148 |
| 70 | regulation of transcription elongation from RNA polymerase II promoter (GO:0034243) | 2.97091516 |
| 71 | protein targeting to Golgi (GO:0000042) | 2.92613766 |
| 72 | DNA methylation involved in gamete generation (GO:0043046) | 2.92036952 |
| 73 | membrane protein ectodomain proteolysis (GO:0006509) | 2.91289547 |
| 74 | peroxisome fission (GO:0016559) | 2.89624687 |
| 75 | DNA ligation (GO:0006266) | 2.86994822 |
| 76 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.84204549 |
| 77 | valine metabolic process (GO:0006573) | 2.81755870 |
| 78 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.78221999 |
| 79 | positive regulation of B cell differentiation (GO:0045579) | 2.77161543 |
| 80 | ectodermal placode formation (GO:0060788) | 2.75356995 |
| 81 | DNA dealkylation (GO:0035510) | 2.75200569 |
| 82 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.72698427 |
| 83 | establishment of protein localization to Golgi (GO:0072600) | 2.72539150 |
| 84 | cytoplasmic microtubule organization (GO:0031122) | 2.72392227 |
| 85 | angiotensin maturation (GO:0002003) | 2.70994562 |
| 86 | negative regulation of histone acetylation (GO:0035067) | 2.63782932 |
| 87 | deoxyribose phosphate metabolic process (GO:0019692) | 2.62887349 |
| 88 | positive regulation of chemokine production (GO:0032722) | 2.60504547 |
| 89 | positive regulation of developmental pigmentation (GO:0048087) | 2.58242277 |
| 90 | phagocytosis (GO:0006909) | 2.57656853 |
| 91 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.57482666 |
| 92 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.57287998 |
| 93 | DNA demethylation (GO:0080111) | 2.54450707 |
| 94 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.53349253 |
| 95 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.53349253 |
| 96 | cellular extravasation (GO:0045123) | 15.1024005 |
| 97 | regulation of chemokine biosynthetic process (GO:0045073) | 13.2373886 |
| 98 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 10.8263223 |
| 99 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 10.8263223 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 10.1729599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.84373945 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 7.79266689 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 6.79611984 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.98461560 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.16602961 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.63226428 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.35660863 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.91153757 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.64167543 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18839223 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05569774 |
| 12 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.05037723 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.02478802 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91974583 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 1.88393005 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.71163920 |
| 17 | MAF_26560356_Chip-Seq_TH2_Human | 1.70480382 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62087377 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 1.57305144 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56943821 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49407596 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45288596 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.45181677 |
| 24 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44580765 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42702579 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42398721 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.40706251 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35582168 |
| 29 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.33645540 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.29947791 |
| 31 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29194675 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28722918 |
| 33 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.28717066 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.28069006 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.25926159 |
| 36 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.21669870 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21653682 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18141288 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.17589306 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17497263 |
| 41 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13356760 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12376816 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.10286604 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10071384 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08224239 |
| 46 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.07648079 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03499862 |
| 48 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03321095 |
| 49 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03018587 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02282100 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01227771 |
| 52 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01163560 |
| 53 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01084492 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00777980 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00342636 |
| 56 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.99706151 |
| 57 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99435292 |
| 58 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98222033 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97174994 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96257677 |
| 61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96107163 |
| 62 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95122790 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95046067 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95035476 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94330056 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91619176 |
| 67 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.90788158 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90651054 |
| 69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89145896 |
| 70 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87557589 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87249466 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85624442 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83427335 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82965930 |
| 75 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82939526 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82924281 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81503317 |
| 78 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.80901338 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79333819 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79246103 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.78435484 |
| 82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78285204 |
| 83 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.78199855 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78176297 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.77176616 |
| 86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76507760 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76348110 |
| 88 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74269312 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.74190664 |
| 90 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.73965584 |
| 91 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73916053 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73853627 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73780393 |
| 94 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73552012 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.73527600 |
| 96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72983016 |
| 97 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.72590012 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72436034 |
| 99 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72391419 |
| 100 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.71714434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 7.24756321 |
| 2 | MP0008877_abnormal_DNA_methylation | 5.45182015 |
| 3 | MP0003878_abnormal_ear_physiology | 4.60726988 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 4.60726988 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.90854846 |
| 6 | MP0005076_abnormal_cell_differentiation | 3.75161356 |
| 7 | MP0000537_abnormal_urethra_morphology | 3.72497620 |
| 8 | MP0003303_peritoneal_inflammation | 3.62953943 |
| 9 | MP0003122_maternal_imprinting | 3.47743013 |
| 10 | MP0008057_abnormal_DNA_replication | 3.47056202 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 3.22898020 |
| 12 | MP0003121_genomic_imprinting | 3.11664620 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.56088536 |
| 14 | MP0001727_abnormal_embryo_implantation | 2.47420872 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.46383769 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.22630639 |
| 17 | MP0005083_abnormal_biliary_tract | 2.09539134 |
| 18 | MP0009672_abnormal_birth_weight | 2.00144663 |
| 19 | MP0000569_abnormal_digit_pigmentation | 1.99589470 |
| 20 | MP0003787_abnormal_imprinting | 1.97254647 |
| 21 | MP0004130_abnormal_muscle_cell | 1.89319222 |
| 22 | MP0009697_abnormal_copulation | 1.86078901 |
| 23 | MP0009278_abnormal_bone_marrow | 1.78808735 |
| 24 | MP0003718_maternal_effect | 1.73439241 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.71717927 |
| 26 | MP0002095_abnormal_skin_pigmentation | 1.68053423 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.51708268 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.49827723 |
| 29 | MP0004381_abnormal_hair_follicle | 1.42388238 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.41234433 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.41234433 |
| 32 | MP0001188_hyperpigmentation | 1.39723247 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.34905883 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.28160955 |
| 35 | MP0004147_increased_porphyrin_level | 1.25874134 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.25694719 |
| 37 | MP0009785_altered_susceptibility_to | 1.22014292 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.17270888 |
| 39 | MP0004233_abnormal_muscle_weight | 1.13657165 |
| 40 | MP0003195_calcinosis | 1.12485809 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.10145352 |
| 42 | MP0003646_muscle_fatigue | 1.06895600 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 0.99583020 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 0.99530290 |
| 45 | MP0001293_anophthalmia | 0.98375943 |
| 46 | MP0003136_yellow_coat_color | 0.97348901 |
| 47 | MP0009379_abnormal_foot_pigmentation | 0.94065078 |
| 48 | MP0009703_decreased_birth_body | 0.93362469 |
| 49 | MP0004036_abnormal_muscle_relaxation | 0.91311886 |
| 50 | MP0003172_abnormal_lysosome_physiology | 0.91235895 |
| 51 | MP0004883_abnormal_blood_vessel | 0.90511419 |
| 52 | MP0002638_abnormal_pupillary_reflex | 0.87491078 |
| 53 | MP0001485_abnormal_pinna_reflex | 0.86825059 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 0.86481069 |
| 55 | MP0003943_abnormal_hepatobiliary_system | 0.86043771 |
| 56 | MP0001853_heart_inflammation | 0.84302299 |
| 57 | MP0008007_abnormal_cellular_replicative | 0.83940848 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 0.83714936 |
| 59 | MP0005266_abnormal_metabolism | 0.83489425 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.82588247 |
| 61 | MP0001486_abnormal_startle_reflex | 0.82089121 |
| 62 | MP0005025_abnormal_response_to | 0.82074703 |
| 63 | MP0002419_abnormal_innate_immunity | 0.81468486 |
| 64 | MP0003111_abnormal_nucleus_morphology | 0.78491645 |
| 65 | MP0005197_abnormal_uvea_morphology | 0.77094088 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.72604418 |
| 67 | MP0000371_diluted_coat_color | 0.70582546 |
| 68 | MP0004957_abnormal_blastocyst_morpholog | 0.69449885 |
| 69 | MP0005409_darkened_coat_color | 0.68678882 |
| 70 | MP0009046_muscle_twitch | 0.67770525 |
| 71 | MP0005451_abnormal_body_composition | 0.63854888 |
| 72 | MP0006292_abnormal_olfactory_placode | 0.61155871 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.58508156 |
| 74 | MP0004197_abnormal_fetal_growth/weight/ | 0.58114912 |
| 75 | MP0005375_adipose_tissue_phenotype | 0.54648153 |
| 76 | MP0002971_abnormal_brown_adipose | 0.54259390 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.54092752 |
| 78 | MP0003077_abnormal_cell_cycle | 0.53682720 |
| 79 | MP0002398_abnormal_bone_marrow | 0.52084750 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.52063884 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.51488622 |
| 82 | MP0008932_abnormal_embryonic_tissue | 0.50520689 |
| 83 | MP0001915_intracranial_hemorrhage | 0.50299254 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 0.49270465 |
| 85 | MP0005164_abnormal_response_to | 0.48985528 |
| 86 | MP0003959_abnormal_lean_body | 0.48277867 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.46980869 |
| 88 | MP0005395_other_phenotype | 0.46280326 |
| 89 | MP0009764_decreased_sensitivity_to | 0.45105668 |
| 90 | MP0005535_abnormal_body_temperature | 0.44827353 |
| 91 | MP0001819_abnormal_immune_cell | 0.44664463 |
| 92 | MP0001440_abnormal_grooming_behavior | 0.44578826 |
| 93 | MP0002722_abnormal_immune_system | 0.44459638 |
| 94 | MP0008874_decreased_physiological_sensi | 0.43490379 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.42503601 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.42444058 |
| 97 | MP0005000_abnormal_immune_tolerance | 0.42392401 |
| 98 | MP0003693_abnormal_embryo_hatching | 0.42325019 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.42194558 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.41915567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 7.31781970 |
| 2 | Eosinophilia (HP:0001880) | 7.17436801 |
| 3 | Congenital stationary night blindness (HP:0007642) | 7.12194261 |
| 4 | Periodontitis (HP:0000704) | 6.93042681 |
| 5 | Pigmentary retinal degeneration (HP:0001146) | 6.64982624 |
| 6 | Difficulty running (HP:0009046) | 6.53305502 |
| 7 | Granulocytopenia (HP:0001913) | 6.41410811 |
| 8 | Abnormality of eosinophils (HP:0001879) | 5.40940434 |
| 9 | Slow saccadic eye movements (HP:0000514) | 5.24008952 |
| 10 | Subacute progressive viral hepatitis (HP:0006572) | 5.16622021 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 5.01852995 |
| 12 | Dyskinesia (HP:0100660) | 4.54356121 |
| 13 | Macular degeneration (HP:0000608) | 4.14928442 |
| 14 | Hypergammaglobulinemia (HP:0010702) | 4.02140679 |
| 15 | Leukocytosis (HP:0001974) | 3.79862620 |
| 16 | Decreased central vision (HP:0007663) | 3.63627721 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.58607175 |
| 18 | Viral hepatitis (HP:0006562) | 3.54935977 |
| 19 | Cone-rod dystrophy (HP:0000548) | 3.49491221 |
| 20 | Ureteral duplication (HP:0000073) | 3.38077296 |
| 21 | Ureteral stenosis (HP:0000071) | 3.28932112 |
| 22 | Ureteral obstruction (HP:0006000) | 3.10713436 |
| 23 | Fair hair (HP:0002286) | 3.04092886 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 2.98043249 |
| 25 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.82487727 |
| 26 | Neonatal hypoglycemia (HP:0001998) | 2.81904224 |
| 27 | Progressive visual loss (HP:0000529) | 2.77514479 |
| 28 | Micronodular cirrhosis (HP:0001413) | 2.76412900 |
| 29 | Loss of speech (HP:0002371) | 2.75218168 |
| 30 | Ocular albinism (HP:0001107) | 2.69663061 |
| 31 | Acanthocytosis (HP:0001927) | 2.68134859 |
| 32 | Generalized hypopigmentation of hair (HP:0011358) | 2.65513836 |
| 33 | Hyperventilation (HP:0002883) | 2.63832583 |
| 34 | Albinism (HP:0001022) | 2.63456182 |
| 35 | Abnormality of the musculature of the hand (HP:0001421) | 2.60422854 |
| 36 | Abnormality of the prostate (HP:0008775) | 2.52590640 |
| 37 | Annular pancreas (HP:0001734) | 2.44651175 |
| 38 | Brushfield spots (HP:0001088) | 2.37385897 |
| 39 | Cholecystitis (HP:0001082) | 2.33414226 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.33414226 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.33055649 |
| 42 | Abnormality of the fingertips (HP:0001211) | 2.25590471 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.24666603 |
| 44 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.24240035 |
| 45 | Absent epiphyses (HP:0010577) | 2.24240035 |
| 46 | Cortical visual impairment (HP:0100704) | 2.23105017 |
| 47 | Rough bone trabeculation (HP:0100670) | 2.22666819 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.22067356 |
| 49 | Abnormality of saccadic eye movements (HP:0000570) | 2.20469340 |
| 50 | Premature graying of hair (HP:0002216) | 2.18584700 |
| 51 | Type I transferrin isoform profile (HP:0003642) | 2.18447942 |
| 52 | Iris hypopigmentation (HP:0007730) | 2.13376035 |
| 53 | Akinesia (HP:0002304) | 2.13102606 |
| 54 | Poikilocytosis (HP:0004447) | 2.11925279 |
| 55 | Polyneuropathy (HP:0001271) | 2.11838682 |
| 56 | Acute myeloid leukemia (HP:0004808) | 2.11799905 |
| 57 | Chromsome breakage (HP:0040012) | 2.11258153 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09168938 |
| 59 | Tubulointerstitial nephritis (HP:0001970) | 2.04640437 |
| 60 | Blue irides (HP:0000635) | 2.02205459 |
| 61 | Amelogenesis imperfecta (HP:0000705) | 2.01831578 |
| 62 | Poor speech (HP:0002465) | 2.01716310 |
| 63 | Thrombocytosis (HP:0001894) | 10.0938076 |
| 64 | Progressive hearing impairment (HP:0001730) | 1.97442796 |
| 65 | Selective tooth agenesis (HP:0001592) | 1.96565467 |
| 66 | Sepsis (HP:0100806) | 1.95917324 |
| 67 | Abnormality of dental color (HP:0011073) | 1.94148030 |
| 68 | Generalized hyperpigmentation (HP:0007440) | 1.92854423 |
| 69 | Short chin (HP:0000331) | 1.92002178 |
| 70 | Widely spaced teeth (HP:0000687) | 1.91668661 |
| 71 | Pseudobulbar signs (HP:0002200) | 1.91502400 |
| 72 | Neutropenia (HP:0001875) | 1.90046875 |
| 73 | Thickened nuchal skin fold (HP:0000474) | 1.89315762 |
| 74 | Capillary hemangiomas (HP:0005306) | 1.85527943 |
| 75 | Obstructive lung disease (HP:0006536) | 1.84881931 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84881931 |
| 77 | Abnormal protein glycosylation (HP:0012346) | 1.84777010 |
| 78 | Abnormal glycosylation (HP:0012345) | 1.84777010 |
| 79 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84777010 |
| 80 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84777010 |
| 81 | Acute lymphatic leukemia (HP:0006721) | 1.83978368 |
| 82 | Epiphyseal stippling (HP:0010655) | 1.81617141 |
| 83 | J-shaped sella turcica (HP:0002680) | 1.80659012 |
| 84 | Premature skin wrinkling (HP:0100678) | 1.79512993 |
| 85 | Cerebellar hypoplasia (HP:0001321) | 1.79339371 |
| 86 | Hypochromic anemia (HP:0001931) | 1.78965160 |
| 87 | Abnormality of male internal genitalia (HP:0000022) | 1.78872684 |
| 88 | Cellular immunodeficiency (HP:0005374) | 1.76948932 |
| 89 | High anterior hairline (HP:0009890) | 1.76574821 |
| 90 | Abnormal pancreas size (HP:0012094) | 1.75818484 |
| 91 | Limb hypertonia (HP:0002509) | 1.73965752 |
| 92 | Lower limb muscle weakness (HP:0007340) | 1.72816399 |
| 93 | Chronic sinusitis (HP:0011109) | 1.70406282 |
| 94 | Difficulty walking (HP:0002355) | 1.70046637 |
| 95 | Postnatal microcephaly (HP:0005484) | 1.69376852 |
| 96 | Abnormality of the columella (HP:0009929) | 1.68582041 |
| 97 | Clumsiness (HP:0002312) | 1.67712008 |
| 98 | Partial agenesis of the corpus callosum (HP:0001338) | 1.67185417 |
| 99 | Central scotoma (HP:0000603) | 1.66693456 |
| 100 | Dyschromatopsia (HP:0007641) | 1.65573251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK3 | 5.59053982 |
| 2 | PIK3CG | 4.77534253 |
| 3 | IRAK3 | 4.50347064 |
| 4 | ICK | 3.73782727 |
| 5 | IRAK2 | 3.63070169 |
| 6 | ERN1 | 3.56824861 |
| 7 | PBK | 3.21032087 |
| 8 | PIK3CA | 2.73910059 |
| 9 | CCNB1 | 2.43448371 |
| 10 | MAP3K2 | 2.36717019 |
| 11 | IRAK1 | 2.36306720 |
| 12 | CDK12 | 2.30088353 |
| 13 | NEK2 | 2.26968687 |
| 14 | TYK2 | 2.12128656 |
| 15 | KSR2 | 2.06858149 |
| 16 | IRAK4 | 1.96929428 |
| 17 | MST4 | 1.86871369 |
| 18 | RPS6KA4 | 1.81028936 |
| 19 | EEF2K | 1.64065012 |
| 20 | ATR | 1.61427384 |
| 21 | RIPK4 | 1.57877709 |
| 22 | MUSK | 1.52617517 |
| 23 | PTK2B | 1.44656541 |
| 24 | STK38 | 1.37435441 |
| 25 | ZAP70 | 1.36068392 |
| 26 | PRKG2 | 1.31809023 |
| 27 | RPS6KB2 | 1.28134108 |
| 28 | TAOK3 | 1.14432973 |
| 29 | MATK | 1.08411042 |
| 30 | PLK2 | 1.07519703 |
| 31 | MAP3K4 | 1.05458766 |
| 32 | KIT | 0.97067062 |
| 33 | CHEK1 | 0.95960844 |
| 34 | NEK6 | 0.93386962 |
| 35 | SCYL2 | 0.92764270 |
| 36 | MAPK11 | 0.92152538 |
| 37 | TTK | 0.90494409 |
| 38 | OBSCN | 0.84962139 |
| 39 | TRPM7 | 0.84771861 |
| 40 | YES1 | 0.82433432 |
| 41 | MAPK4 | 0.81227375 |
| 42 | LCK | 0.80583760 |
| 43 | TAOK1 | 0.80002066 |
| 44 | MAP3K10 | 0.78471962 |
| 45 | HIPK2 | 0.78151149 |
| 46 | CDK2 | 0.73966662 |
| 47 | PRKAA1 | 0.73511790 |
| 48 | SRPK1 | 0.72102853 |
| 49 | PLK4 | 0.68616669 |
| 50 | PLK1 | 0.66154605 |
| 51 | MTOR | 0.64681691 |
| 52 | CDK1 | 0.63592638 |
| 53 | SYK | 0.62031666 |
| 54 | CHEK2 | 0.61004185 |
| 55 | PRKAA2 | 0.60427808 |
| 56 | BMPR2 | 0.58818897 |
| 57 | TYRO3 | 0.58304174 |
| 58 | VRK1 | 0.57943689 |
| 59 | GSK3B | 0.56058713 |
| 60 | MAPK14 | 0.55777496 |
| 61 | CSNK2A2 | 0.55663270 |
| 62 | RPS6KB1 | 0.55519935 |
| 63 | RPS6KA1 | 0.52988794 |
| 64 | TRIB3 | 0.48754812 |
| 65 | AURKB | 0.48652645 |
| 66 | RPS6KA5 | 0.48185776 |
| 67 | HCK | 0.46306159 |
| 68 | MAPK8 | 0.45715898 |
| 69 | AKT1 | 0.45611687 |
| 70 | WEE1 | 0.44916503 |
| 71 | RET | 0.44871526 |
| 72 | PRKCI | 0.43384151 |
| 73 | CDC7 | 0.43159931 |
| 74 | IKBKE | 0.42292787 |
| 75 | JAK2 | 0.41475790 |
| 76 | FLT3 | 0.41270296 |
| 77 | BRD4 | 0.39558596 |
| 78 | CSNK2A1 | 0.38060780 |
| 79 | TAOK2 | 0.36151361 |
| 80 | BMX | 0.35458095 |
| 81 | RPS6KA6 | 0.35070292 |
| 82 | CDC42BPA | 0.34955696 |
| 83 | RPS6KA3 | 0.34353939 |
| 84 | CSNK1E | 0.33809298 |
| 85 | PTK6 | 0.33361906 |
| 86 | MKNK2 | 0.32674209 |
| 87 | BTK | 0.32660574 |
| 88 | EGFR | 0.31260419 |
| 89 | PDGFRB | 0.31219428 |
| 90 | GRK6 | 0.31203894 |
| 91 | NUAK1 | 0.31154992 |
| 92 | CLK1 | 0.30147088 |
| 93 | MKNK1 | 0.28974884 |
| 94 | RPS6KC1 | 0.28097226 |
| 95 | RPS6KL1 | 0.28097226 |
| 96 | IGF1R | 0.27235949 |
| 97 | CSF1R | 0.25886750 |
| 98 | MAP3K1 | 0.25662851 |
| 99 | CSK | 0.25178374 |
| 100 | MAPK3 | 0.25083109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 6.30873245 |
| 2 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 4.10093272 |
| 3 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.67983043 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.53542138 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.73363842 |
| 6 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.35843423 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.23399243 |
| 8 | Endometrial cancer_Homo sapiens_hsa05213 | 2.03971114 |
| 9 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.92462251 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.84843429 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.83909915 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.83602402 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.74036066 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.70862351 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67344465 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62645992 |
| 17 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.47053841 |
| 18 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.42588818 |
| 19 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.39716264 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36424455 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36109460 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33939577 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31024814 |
| 24 | Colorectal cancer_Homo sapiens_hsa05210 | 1.29067930 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.27348971 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23611544 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22946244 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22102429 |
| 29 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.19874748 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.17549229 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.14278503 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13243215 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04920512 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96525421 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94515328 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 0.94389102 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94292479 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93415567 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93198167 |
| 40 | Glioma_Homo sapiens_hsa05214 | 0.92272850 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.91488918 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 0.91393304 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89645175 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88221085 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87722273 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86247708 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85284564 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 0.84207492 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81489462 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81341328 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 0.80273106 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79885821 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78409658 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74714696 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74178054 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72873889 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72829451 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71513286 |
| 59 | Melanoma_Homo sapiens_hsa05218 | 0.70527945 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69526899 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68313627 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66835142 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63198966 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63073418 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62519068 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61839545 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60487548 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59037616 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57463922 |
| 70 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57130058 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56145117 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54584333 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52935228 |
| 74 | RNA transport_Homo sapiens_hsa03013 | 0.52684118 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52366214 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.51708110 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48756406 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47736862 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47668757 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.47379818 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.45977759 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44801062 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43714852 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43131686 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41623622 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39980269 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39569749 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37695156 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37077917 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37028764 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33311982 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33064133 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30191396 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.28386764 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.27238870 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27130988 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.26998003 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26925666 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26744684 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24915893 |

